Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 2021

View Archived Issues

First clinical data presented for BNT-211 in patients with CLDN6-positive solid tumors

Phase I dose-escalation study tests combination immunotherapy with belapectin and pembrolizumab

Galectin-3 mediates the crosstalk between the WNT and STAT3 signaling pathways in gastric cancer

Ono Pharmaceutical, Vanderbilt University present KCNT1/KCNK2 blockers

ReViral synthesizes new benzodiazepine derivatives

New anti-HBV compounds identified at Sunshine Lake Pharma

Suzhou Raymon Pharmaceuticals discovers PI3K-alpha inhibitors

ShanghaiTech University, Fudan University patent new PROTACs

New Angex Pharmaceutical anticancer compounds show preclinical potential

Full-data analysis from 12-month treatment phase of ALTISSIMO study in wet AMD

Nephraegis Therapeutics to develop NPH-022 for the prevention and treatment of AKI

New phase II trial evaluates CBP-201 for moderate to severe persistent asthma

Mitsubishi Tanabe discontinues development of MT-5745 for ulcerative colitis

Inovio reports preclinical data on next-generation pan-COVID-19 vaccine candidate INO-4802

Mabwell initiates first-in-human study of 9MW-1411

China's NMPA issues clinical trial approval for JS-103 for gout

Preclinical characterization of novel 3CL(pro) inhibitors against COVID-19

Clene Nanomedicine presents preliminary phase II data for CNM-Au8 in ALS

HU-6 enters phase II development as potential treatment of NASH

OCS-02 shows safety and efficacy in phase II study in patients with acute anterior uveitis

Dosing begins in phase II trial of onapristone and anastrozole in endometrial cancer

Xilio presents preclinical data on tumor-selective anti-CTLA-4 antibody XTX-101

AzurRx reports phase II interim data on MS-1819 for severe exocrine pancreatic insufficiency

Engineering blood cells can treat brain diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...